Report Library
All Reports
2016 Biomedtracker ASCO Survey
July 12, 2016
We performed a 5-question survey of 39 United States and European (France, Germany, Italy, and United Kingdom) oncologists after the
American Society of Clinical Oncology (ASCO) meeting to gauge interest in new data presented on drugs in clinical development.
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys through 2016 for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
If you are a KOL Insight Subscriber, please access this report here, in our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys through 2016 for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
If you are a KOL Insight Subscriber, please access this report here, in our KOL Insight portal (Subscribers only).
| Indications Covered: |
Breast Cancer
Mesothelioma Solid Tumors |
Additional Resources: